2013
DOI: 10.1016/j.biomaterials.2012.11.016
|View full text |Cite
|
Sign up to set email alerts
|

Solid tumor penetration by integrin-mediated pegylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
67
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 93 publications
(69 citation statements)
references
References 29 publications
2
67
0
Order By: Relevance
“…45,46 This is supported by a recent publication. 47 The results from either of these spheroid models could be useful in relative studies comparing penetration of different NP delivery systems. However, we believe that the slower and lower penetration in the organotypic slices is much more representative of normal tissue in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…45,46 This is supported by a recent publication. 47 The results from either of these spheroid models could be useful in relative studies comparing penetration of different NP delivery systems. However, we believe that the slower and lower penetration in the organotypic slices is much more representative of normal tissue in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Poly(hydroxyalkanoates) (PHAs) and poly(carbonates) (PCs) have attracted considerable attention for the design of drug delivery systems due to their high biocompatibility and low toxicity (Furrer et al, 2008;Wu et al, 2009;Hazer, 2010;Hu et al, 2012;Shrivastav et al, 2013;Chen et al, 2014;Loyer and Cammas-Marion, 2014;Li and Loh, 2015;Nigmatullin et al, 2015). In this context, poly(3-hydroxybutyrate) and poly(trimethylene carbonate) have been developed to produce gels and matrices for tissue engineering (Shishatskaya et al, 2004 ;Asran et al, 2010 ;Song et al, 2011 ;SchĂźller-Ravoo et al, 2013 ;Rozila et al, 2016 ;Ding et al, 2016 ;Pascu et al, 2016 ;Zant et al, 2016) and NPs for drug delivery (Xiong et al, 2010 ;Jiang et al, 2013 ;Fukushima 2016 ;Pramual et al, 2016). Our laboratories have recently synthesized and characterized novel poly(hydroxyalkanoate)-based 7 amphiphilic diblock copolymers, namely poly(-malic acid)-b-poly(3-hydroxybutyrate) (PMLA-b-PHB) (Barouti et al, 2015) and poly(-malic acid)-b-poly(trimethylene carbonate) (PMLA-b-PTMC) (Barouti et al, 2016a), hydrophobic PMLA Be -b-PHB-b-PMLA Be and amphiphilic PMLA-b-PHB-b-PMLA triblock copolymers (Barouti et al, 2016b) as well as linear and star-shaped thermogelling poly([R]-3-hydroxybutyrate) copolymers (Barouti et al, 2016c).…”
mentioning
confidence: 99%
“…Their study demonstrated that the targeted NP had stronger drug distribution in tumor tissue and was more efficient at inhibiting tumor growth and neovascularization in vivo [164]. In another study, Jiang et al showed that integrinmediated poly(trimethylene carbonate)-based stealth NPs, c(RGDyK)-NP, loaded with paclitaxel had greater tumor penetration, accumulation, and growth inhibitory effect than other conventional NPs [167].…”
Section: Targeting the Tumor Vasculaturementioning
confidence: 96%